IRIS
FORNARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.294
EU - Europa 1.559
AS - Asia 1.458
SA - Sud America 350
Continente sconosciuto - Info sul continente non disponibili 230
AF - Africa 91
OC - Oceania 4
Totale 5.986
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.212
SG - Singapore 676
IT - Italia 550
BR - Brasile 268
DE - Germania 221
CN - Cina 212
RU - Federazione Russa 196
FI - Finlandia 157
HK - Hong Kong 142
SE - Svezia 137
FR - Francia 108
VN - Vietnam 107
GB - Regno Unito 68
IN - India 59
BD - Bangladesh 55
CA - Canada 53
AR - Argentina 37
JP - Giappone 33
ZA - Sudafrica 31
CI - Costa d'Avorio 27
IQ - Iraq 25
PL - Polonia 23
ID - Indonesia 22
TR - Turchia 22
MX - Messico 19
NL - Olanda 18
PK - Pakistan 17
BE - Belgio 14
EC - Ecuador 14
SA - Arabia Saudita 14
AT - Austria 13
PH - Filippine 13
LT - Lituania 9
VE - Venezuela 9
UA - Ucraina 8
UZ - Uzbekistan 8
CO - Colombia 7
CZ - Repubblica Ceca 7
ES - Italia 7
IR - Iran 7
CL - Cile 6
KE - Kenya 6
MA - Marocco 6
MY - Malesia 6
TN - Tunisia 6
AM - Armenia 5
JM - Giamaica 5
KZ - Kazakistan 5
PY - Paraguay 5
AU - Australia 4
CH - Svizzera 4
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
LB - Libano 3
SI - Slovenia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
IE - Irlanda 2
KR - Corea 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CM - Camerun 1
DK - Danimarca 1
GF - Guiana Francese 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
MK - Macedonia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TL - Timor Orientale 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.756
Salva come PNG Salva come JPEG
Città #
Singapore 389
Ashburn 364
San Jose 200
Chandler 170
Milan 166
Hong Kong 142
Munich 138
Helsinki 120
Fairfield 115
Nyköping 114
Beijing 97
Los Angeles 66
Dallas 63
New York 60
Houston 58
Lauterbourg 53
Cambridge 50
Rome 49
Woodbridge 43
Bari 41
Moscow 41
Seattle 40
Columbus 36
Wilmington 36
Falkenstein 33
Ho Chi Minh City 32
São Paulo 32
Council Bluffs 31
Santa Clara 28
Abidjan 27
Ann Arbor 27
Boardman 27
Hanoi 26
Lawrence 26
Figino 25
Turku 22
Buffalo 21
Warsaw 20
Tokyo 19
Roxbury 18
Chicago 17
Frankfurt am Main 17
Inglewood 17
Johannesburg 17
Montreal 16
London 15
Toronto 15
Brussels 14
Des Moines 13
Brooklyn 12
Denver 12
Poplar 12
El Paso 11
Jakarta 11
San Francisco 11
Florence 10
Naples 10
Stockholm 10
Manchester 9
Mexico City 9
Orem 9
Paris 9
Phoenix 9
Princeton 9
Amsterdam 8
Bacolod City 8
Baghdad 8
Jyväskylä 8
Mumbai 8
Pescara 8
Atlanta 7
Boston 7
Chennai 7
Dhaka 7
Pittsburgh 7
Rio de Janeiro 7
Ankara 6
Bengaluru 6
Nuremberg 6
Redwood City 6
Riyadh 6
Salt Lake City 6
Tashkent 6
Turin 6
Belo Horizonte 5
Da Nang 5
Düsseldorf 5
Haiphong 5
Illkirch-Graffenstaden 5
Modugno 5
Nairobi 5
Ottawa 5
Porto Alegre 5
Pune 5
Quito 5
Shanghai 5
Tunis 5
Vienna 5
Yerevan 5
Brno 4
Totale 3.576
Salva come PNG Salva come JPEG
Nome #
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 227
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 198
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 186
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 177
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 176
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 172
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 167
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 163
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 147
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 140
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 133
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 129
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 121
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 119
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 118
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 117
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 113
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 110
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 105
Cartilage damage: clinical approach 104
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 102
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 102
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 101
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 100
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 98
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 97
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 96
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 96
Complete Hydatidiform Mole Mimicking Sacroiliitis 94
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 93
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 92
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 89
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 88
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 87
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 87
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 86
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 85
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 78
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 73
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 69
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry 69
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 69
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry 68
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 68
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 67
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 67
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 67
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis 66
Letters to the editors 65
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 63
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 63
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 55
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 50
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies 43
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 37
Predictors of long-term clinical remission in rheumatoid arthritis 37
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 31
Mobile session fixation attack in micropayment systems 31
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study 30
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity 27
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 27
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 26
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 25
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 22
Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers 22
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al‘ by Agca et al 21
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 21
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 10
Sjögren’s disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment 4
Totale 5.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 9 2 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024221 17 45 13 19 13 41 9 6 3 7 3 45
2024/20251.364 42 13 62 26 25 136 188 247 65 95 174 291
2025/20263.123 388 151 218 350 415 170 284 105 304 307 106 325
2026/2027123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 5.986